189 related articles for article (PubMed ID: 33029226)
1. CUSHING'S SYNDROME, A RISK FACTOR FOR VENOUS THROMBOEMBOLISM IS A CANDIDATE FOR GUIDELINES.
Koraćević G; Stojanović M; Petrović S; Simić D; Sakač D; Vlajković M; Stevic M; Kocić M; Đorđević M; Koraćević M
Acta Endocrinol (Buchar); 2020; 16(2):123-128. PubMed ID: 33029226
[TBL] [Abstract][Full Text] [Related]
2. A venous thromboembolism risk assessment model for patients with Cushing's syndrome.
Zilio M; Mazzai L; Sartori MT; Barbot M; Ceccato F; Daidone V; Casonato A; Saggiorato G; Noventa F; Trementino L; Prandoni P; Boscaro M; Arnaldi G; Scaroni C
Endocrine; 2016 May; 52(2):322-32. PubMed ID: 26113424
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
Isand K; Feelders R; Brue T; Toth M; Deutschbein T; Reincke M; Kršek M; Santos A; Demtröder F; Chabre O; Strasburger CJ; Aulinas Maso A; Volke V; Pereira AM; Lohmann R; Gich Saladich I; ; Webb SM; Wass J; Valassi E
Eur J Endocrinol; 2024 Jan; 190(1):75-85. PubMed ID: 38146835
[TBL] [Abstract][Full Text] [Related]
4. The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Bryk-Wiązania AH; Minasyan M; Świątkowska-Stodulska R; Undas A; Hubalewska-Dydejczyk A; Webb SM; Valassi E; Gilis-Januszewska A
Front Endocrinol (Lausanne); 2024; 15():1350010. PubMed ID: 38529392
[TBL] [Abstract][Full Text] [Related]
5. Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
Stuijver DJ; van Zaane B; Feelders RA; Debeij J; Cannegieter SC; Hermus AR; van den Berg G; Pereira AM; de Herder WW; Wagenmakers MA; Kerstens MN; Zelissen PM; Fliers E; Schaper N; Drent ML; Dekkers OM; Gerdes VE
J Clin Endocrinol Metab; 2011 Nov; 96(11):3525-32. PubMed ID: 21880802
[TBL] [Abstract][Full Text] [Related]
6. Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis.
Wagner J; Langlois F; Lim DST; McCartney S; Fleseriu M
Front Endocrinol (Lausanne); 2018; 9():805. PubMed ID: 30745894
[No Abstract] [Full Text] [Related]
7. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulable state in Cushing's syndrome: a systematic review.
Van Zaane B; Nur E; Squizzato A; Dekkers OM; Twickler MT; Fliers E; Gerdes VE; Büller HR; Brandjes DP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2743-50. PubMed ID: 19454584
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols.
Feelders RA; Nieman LK
Pituitary; 2022 Oct; 25(5):746-749. PubMed ID: 35881275
[TBL] [Abstract][Full Text] [Related]
10. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
[TBL] [Abstract][Full Text] [Related]
11. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
12. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
13. Venous thrombotic events in psoriasis patients: a systematic review with meta-analysis.
Hillary T; Clijmans J; Vermeire S; Lambert J; Garmyn M; Imbrechts M; Vanassche T
Ann Med; 2021 Dec; 53(1):1074-1081. PubMed ID: 34184588
[TBL] [Abstract][Full Text] [Related]
14. A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease.
Kemp MT; Obi AT; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1557-1567. PubMed ID: 33866055
[TBL] [Abstract][Full Text] [Related]
15. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
16. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
17. Portal Vein Thrombosis in the Setting of Newly Diagnosed Cushing's Syndrome.
McDow AD; Gurung A; Poola R; Fratianni C; Garfinkel M; Jakoby MG
J Investig Med High Impact Case Rep; 2017; 5(2):2324709617703672. PubMed ID: 28491882
[TBL] [Abstract][Full Text] [Related]
18. Preventive strategies for hypercoagulation in Cushing's syndrome: when and how.
Lopes V; Marques O; De Sousa Lages A
Thromb J; 2023 Jul; 21(1):72. PubMed ID: 37400845
[TBL] [Abstract][Full Text] [Related]
19. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
[TBL] [Abstract][Full Text] [Related]
20. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
